ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

SLGL Sol Gel Technologies Ltd

0.80
0.079 (10.96%)
May 31 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 46,575
Bid Price 0.88
Ask Price 0.9351
News -
Day High 0.82

Low
0.6311

52 Week Range

High
4.0498

Day Low 0.7103
Company Name Stock Ticker Symbol Market Type
Sol Gel Technologies Ltd SLGL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.079 10.96% 0.80 17:54:47
Open Price Low Price High Price Close Price Prev Close
0.758 0.7103 0.82 0.80 0.721
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
303 46,575 $ 0.801967 $ 37,352 - 0.6311 - 4.0498
Last Trade Time Type Quantity Stock Price Currency
16:00:00 100 $ 0.80 USD

Sol Gel Technologies Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
22.29M 27.86M - 1.61M -27.24M -0.98 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sol Gel Technologies News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SLGL Message Board. Create One! See More Posts on SLGL Message Board See More Message Board Posts

Historical SLGL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.800.82140.71030.775497715,4730.000.00%
1 Month0.870.890.63110.747567338,100-0.07-8.05%
3 Months1.081.110.63110.876587233,257-0.28-25.93%
6 Months1.281.57540.63111.0331,029-0.48-37.50%
1 Year3.504.04980.63111.5121,444-2.70-77.14%
3 Years10.3214.500.63115.2118,049-9.52-92.25%
5 Years8.4926.520.63119.1027,917-7.69-90.58%

Sol Gel Technologies Description

Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.